FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease

29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...

Read more →

Overall survival, progression-free survival and tumour response benefit supporting initial US FDA approval and indication extension of new cancer drugs, 2003-2021

10 August 2022 - Clinical trial evidence is routinely evaluated for initial drug approvals, yet the benefit of indication extensions remains ...

Read more →

EU regulator begins review of Pfizer-BioNTech's variant adapted COVID shot

9 August 2022 - The EMA has started a rolling review of a variant-adapted COVID-19 vaccine from Pfizer and BioNTech, ...

Read more →

Few U.S. patients with hepatitis C get timely treatment, CDC says

9 August 2022 - Few U.S. adults diagnosed with hepatitis C virus infection receive timely treatment with anti-viral drugs, the ...

Read more →

FDA authorises emergency use of Jynneos vaccine to increase vaccine supply

9 August 2022 - Today, the U.S. FDA  issued an emergency use authorisation for the Jynneos vaccine to allow health care ...

Read more →

Has the innovative pharmaceutical industry essential given up trying to list new medicines in New Zealand?

10 August 2022 - Upon examining the agenda for this month's PTAC meeting, one would think that it has. ...

Read more →

Network collaborators announced for CADTH’s post-market drug evaluation network

8 August 2022 - CADTH is pleased to announce the successful collaborators of its inaugural Post-Market Drug Evaluation Network.  ...

Read more →

Challenges of health technology assessment in pluralistic healthcare systems: an ISPOR Council report

9 August 2022 - Health technology assessment has been growing in use over the past 40 years, especially in its impact ...

Read more →

Paladin Labs announces Health Canada's filing acceptance of cenobamate tablets as an adjunctive therapy for the management of partial-onset seizures in adults with epilepsy

8 August 2022 - Paladin Labs announced today that Health Canada has accepted its new drug submission for cenobamate tablets as ...

Read more →

Introducing CADTH’s RWE Guidance Working Group

9 August 2022 - CADTH is pleased to announce the introduction of the Real-World Evidence Guidance Working Group.  ...

Read more →

Relmada Therapeutics receives FDA fast track designation for REL-1017 as a monotherapy for the treatment of major depressive disorder

9 August 2022 - Relmada Therapeutics today announced that the U.S. FDA has granted fast track designation to REL-1017, the Company's ...

Read more →

CorMedix announces regulatory and manufacturing updates

8 August 2022 - CorMedix today announced a second complete response letter was received from the FDA stating that the DefenCath ...

Read more →

Reata Pharmaceuticals announces three month extension of the review period for new drug application for omaveloxolone for the treatment of Friedreich’s ataxia

9 August 2022 - PDUFA date extended to 28 February 2023. ...

Read more →

Monkeypox vaccines: here’s how many have been shipped and where as White House declares public health emergency

8 August 2022 - The US Government has shipped more than 602,000 doses of Jynneos monkeypox vaccines—the only shot specifically approved ...

Read more →

Monkeypox vaccines have arrived in Victoria. Here's how the rollout will work.

9 August 2022 - As concern about how to curb monkeypox continues at a global level, the first few thousand ...

Read more →

The GOP blocked an insulin price cap: What it means for diabetics

8 August 2022 - The Senate passed a sweeping budget package Sunday intended to bring financial relief to Americans, but ...

Read more →